Norris Medicines reports standalone net loss of Rs 0.37 crore in the June 2024 quarter
Sales decline 24.21% to Rs 0.72 crore
Net Loss of Norris Medicines reported to Rs 0.37 crore in the quarter ended June 2024 as against net loss of Rs 0.61 crore during the previous quarter ended June 2023. Sales declined 24.21% to Rs 0.72 crore in the quarter ended June 2024 as against Rs 0.95 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales0.720.95 -24 OPM %-23.61-40.00 -PBDT-0.24-0.47 49 PBT-0.37-0.61 39 NP-0.37-0.61 39Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content